ifinatamab deruxtecan
daiichi sankyo
['ds7300', 'daiichi']
#daiichisankyo reported that #ds7300 continues to show promising durable response in patients with several types of advanced #cancer #esmo22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.